GE HealthCare Gets 510(k) Clearance From FDA For Portrait Mobile Monitoring Solution
(RTTNews) - GE HealthCare (GEHC) announced Monday it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Portrait Mobile wireless and wearable monitoring solution.
The Portrait Mobile platform enables real-time continuous monitoring with a personalized view of the patient's vitals while keeping patients mobile during critical recovery periods, especially after surgery or discharge from the intensive care unit.
The wireless patient-worn sensors combined with the smart phone-sized monitor eliminate all traditional tethers, allowing patients to move about the ward freely, key to helping improve outcomes and reduce length of stay.
The uninterrupted flow of data and continuous measurement of vital signs, such as respiration rate, oxygen saturation and pulse rate, can help healthcare providers detect patient decline as it is happening, enabling timely intervention before a patient deteriorates.
Portrait Mobile is part of GE HealthCare's FlexAcuity monitoring solutions that combine hardware and software engineered to adapt to rapidly changing patient needs and builds on a well-established history of clinical advancements.
GE HealthCare Shares Rise 7% On Higher Q3 Results, FY26 Outlook Upgrade
GE HealthCare Stock Up 13% On Strong Q2 Profit & Orders, Positive Outlook
GE HealthCare Q4 Profit Declines
GE HealthCare Q4 Preliminary Revenue Up About 7% To About $4.9 Bln
Energy Stocks Shine In Canadian Market; BoC Raises Interest Rate
NZ Dollar Falls As RBNZ Holds Key Rate Defying Market Expectation
Bank Of Canada Raises Rates By Quarter Point Amid Rising Cost Pressures
